SCHEMBL6607779

SCHEMBL6607779

CC1=C(C#N)C(c2cc(-c3cccnc3)ccc2F)NC(=O)N1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ CYP11B2 P19099 12/20 0.37
▸ CYP11B1 P15538 10/20 0.37
▸ ABCB1 P08183 3/20 0.37
▸ ELANE P08246 1/20 0.36
▸ MKNK1 Q9BUB5 1/20 0.36
▸ MKNK2 Q9HBH9 1/20 0.36
▸ CYP1A2 P05177 3/20 0.36
▸ CYP17A1 P05093 2/20 0.36
▸ CYP19A1 P11511 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6609381 0.85 CACNA1C (0.41) MEN1ALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL6607566 0.85 CYP11B2 (0.39) ALDH1A1SMN1; SMN2CYP11B2CYP11B1ELANE
SCHEMBL6608080 0.85 ALDH1A1 (0.40) MEN1ALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL6312361 0.80 ALDH1A1 (0.42) MEN1ALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL6313542 0.78 CACNA1C (0.40) MEN1ALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL6606626 0.73 CYP11B2 (0.38) ALDH1A1CYP11B2CYP11B1ELANECYP1A2
SCHEMBL6137082 0.71 TDP1 (0.50) MEN1ALDH1A1MAPTKMT2AELANE
SCHEMBL6311789 0.67 ALDH1A1 (0.42) MEN1ALDH1A1MAPTKMT2ASMN1; SMN2
SCHEMBL6609236 0.67 ELANE (0.45) ABCB1ELANE
SCHEMBL6137365 0.66 ELANE (0.40) MEN1ALDH1A1MAPTKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373223-A4 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL MYERS SQUIBB CO (US) 2004-09-29 — — EP claimed
EP-1373223-A1 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES Bristol-Myers Squibb Company (US) 2004-01-02 — — EP claimed
WO-2002079169-A1 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-10-10 — — WO claimed
EP-1373223-A4 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL MYERS SQUIBB CO (US) 2004-09-29 — — EP disclosed
EP-1373223-A1 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES Bristol-Myers Squibb Company (US) 2004-01-02 — — EP disclosed
WO-2002079169-A1 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-10-10 — — WO disclosed
Send feedback